Role of myocyte nitric oxide in β-adrenergic hyporesponsiveness in heart failure

Circulation

Volumn 95, Issue 5, 1997, Pages 1111-1114

  Yamamoto, Shimako ^a   Tsutsui, Hiroyuki ^a,b   Tagawa, Hirofumi ^a   Saito, Keiko ^a   Takahashi, Masaru ^a   Tada, Hideo ^a   Yamamoto, Mitsutaka ^a   Katoh, Makoto ^a   Egashira, Kensuke ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

cells; contractility; endothelium derived factors; heart failure; receptors, adrenergic, beta

Indexed keywords

ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BETA ADRENERGIC STIMULATION; CELL ISOLATION; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART PACING; INOTROPISM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SARCOMERE;

EID: 0141857044     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.5.1111     Document Type: Article

References (10)

1. Tsutsui H, Spinale FG, Nagatsu M, Schmid PG, Ishihara K, DeFreyte G, Cooper G, Carabello BA. Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest. 1994;93:2639-2648.
2. Tanaka R, Fulbright BM, Mukherjee R, Burchell SA, Crawford FA, Zile MR, Spinale FG. The cellular basis for the blunted response to β-adrenergic stimulation in supraventricular tachycardia-induced cardiomyopathy. J Mol Cell Cardiol. 1993;25:1215-1233.
3. Balligand J-L, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A. 1993;90:347-351.
4. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Hording SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol. 1993;265:H176-H182.
5. Hare JM, Colucci WS. Role of nitric oxide in the regulation of myocardial function. Prog Cardiovasc Dis. 1995;38:155-166.
6. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB. Expression of inducible nitric oxide synthase in human heart failure. Circulation. 1996;93:1087-1094.
7. Hare JM, Loh EL, Creager MA, Colucci WS. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 1995;92:2198-2203.
8. Ishibashi Y, Tsutsui H, Yamamoto S, Takahashi M, Imanaka-Yoshida K, Yoshida T, Urabe Y, Sugimachi M, Takeshita A. Role of microtubules for myocyte contractile dysfunction during cardiac hypertrophy in the rat. Am J Physiol. 1996;271:H1978-H1987.
9. Bredt DS, Snyder SH. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A. 1990;87:682-685.
10. Kanai AJ, Mesaros S, Finkel MS, Oddis DV, Strauss HC, Malinski T. Nitric oxide release measured directly with a porphyrinic microsensor reveals adrenergic control of constitutive nitric oxide synthase in cardiac myocytes. Circulation. 1995;92(suppl I): I-563. Abstract.